Filing Flows › Stryker (SYK) › Q3 2025
Stryker (SYK) Q3 2025 earnings results (third quarter 2025)
10-Q filed Oct 31, 2025
Stryker (SYK) reported revenue of $6.1B for the third quarter 2025 (Q3 2025), +10% from a year earlier and +0.6% from the quarter before. Operating margin was 18.7%, net earnings $859M (14.2% of revenue).
Stryker, Q3 2025: revenue $6.1B (+10% year over year), operating margin 18.7%, net earnings $859M, operating cash flow $1.5B. The chart follows the revenue to costs, profit and cash.
| Q3 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $6.1B | +0.6% | +10% |
| Gross profit | $3.9B | +0.3% | +10% |
| Operating profit | $1.1B | +2% | +5% |
| Net earnings | $859M | -3% | +3% |
| Operating cash flow | $1.5B | +39% | +4% |
| Free cash flow | $1.4B | +46% | +4% |
What changed
Revenue was $6.1B in Q3 2025, up 10% year over year and up 1% from the previous quarter. MedSurg and Neurotechnology: was the largest line at 63% of revenue. MedSurg and Neurotechnology: added $0.48B year over year (up 14%), 85% of the total change.
Gross margin was 63.6%, down 0.4 points from a year earlier. Operating profit was $1.1B, a 18.7% margin (down 1.0 points year over year). Of the extra revenue versus a year earlier, 9% reached operating profit, below the 20% margin then. Operating expenses grew 12% against revenue growth of 10%. The fastest-growing cost line was Other operating costs (+63%). Net earnings were $0.86B, up 3% year over year. The effective tax rate was 16.5%.
Operating cash flow was $1.5B (up 4% year over year), 179% of net earnings. Non-cash charges added back $0.40B of depreciation and amortization and $0.06B of share-based compensation. Working capital and other items added $0.22B. Capital expenditures of $0.19B left free cash flow of $1.4B.
Questions
What was Stryker's revenue in the third quarter 2025?
Stryker (SYK) reported revenue of $6.1B for the third quarter 2025 (Q3 2025), +10% from a year earlier and +0.6% from the quarter before.
Was Stryker profitable in the third quarter 2025?
Operating profit was $1.1B (18.7% of revenue) and net earnings $859M.
Source: Stryker 10-Q on SEC EDGAR.